Sveriges mest populära poddar
Plenary Session
Hälsa och motionMedicin

1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández

1 tim 17 min•13 februari 2019
In the first half of this episode, Dr. Sven Olson of OHSU joins us to help critique the recent NEJM paper, "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura". In the second half, we interview Dr. Inmaculada Hernández of the University of Pittsburgh on her work on the economic principles behind runaway drug prices. Caplacizumab: doi.org/10.1056/NEJMoa1806311 Back us on Patreon! www.patreon.com/plenarysession

Fler avsnitt av Plenary Session

Visa alla avsnitt av Plenary Session
Longevity Episode 2 - Nutrition science
•37 min
Longevity Lecture series Introduction and Lecture 1
•29 min
CABINET - trial - Cabozantinib for NET
•19 min
CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!
•39 min
Why the NIH is a broken funding system
•32 min
Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints
•23 min
Trump is breaking media brains / NIH cuts indirect payments and scientists freak out
•27 min
RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom
•28 min
Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!
•29 min
The ENTIRE healthcare system is broken, not just health insurance companies
•19 min

Plenary Session med Vinay Prasad, MD MPH finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.